Newswise — New Brunswick, N.J., December 2, 2020 Bruce G. Haffty, MD,  associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been chosen as the 2021 president-elect of the Radiological Society of North America (RSNA), an international society of radiologists, medical physicists and other medical professionals across the world, which was announced at the society’s annual meeting held in Chicago.

As president-elect, Dr. Haffty, who is also chair of radiation oncology at Rutgers Robert Wood Johnson Medical School and New Jersey Medical School, will focus on maintaining strong governance of the society and raise the profile of RSNA and radiology beyond the radiology community.

“As an RSNA leader, I am honored to have the opportunity to make a significant impact throughout the radiological community and support the mission of the RSNA by promoting excellence in patient care and health care delivery through education, research and technologic innovation,” said Haffty. “I am also looking forward to exploring collaborations with other organizations that will be beneficial for our Society and our specialty.”

Haffty joined Rutgers Cancer Institute in 2005, and has since overseen the growth of the Radiation Oncology Program to offer numerous sub-specialties and technologies not generally offered in a community setting, including proton therapy. Through decades of knowledge and experience, he also guides radiation oncology practices at University Hospital in Newark and throughout the Oncology Service Line at RWJBarnabas Health. Haffty is a leader in national clinical trials and is currently co-investigator on several national clinical trials through the NRG Oncology and Alliance for Clinical Trials in Oncology cooperative groups.

As a previous volunteer with RSNA in a number of roles, Haffty has served as third vice president from 2013 to 2014 and as co-chair of the Bolstering Oncoradiologic and Oncoradiotherapeutic Skills for Tomorrow (BOOST) Program. At RSNA 2009, he delivered the Annual Oration in Radiation Oncology, “Genetic Factors in the Diagnostic Imaging and Radiotherapeutic Management of Breast Cancer.” Dr. Haffty was named RSNA Outstanding Educator in 2013. He has been on the RSNA Board of Directors since 2014, most recently serving as chair.

Haffty has served in many other leadership roles related to research and education in radiation oncology. He has served as president of the American Board of Radiology, the major certifying organization for the practice of diagnostic radiology, radiation oncology, and medical physics. He also served as president and chairman of the board of ASTRO, has served as a past president of the American Radium Society and past chairman of the Residency Review Committee in Radiation Oncology. He currently serves on the editorial board of The Breast Journal and serves as deputy editor of Journal of Clinical Oncology.


About Rutgers Cancer Institute of New Jersey

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, together with RWJBarnabas Health, offers the most advanced cancer treatment options including bone marrow transplantation, proton therapy, CAR T-cell therapy and complex surgical procedures.  Along with clinical trials and novel therapeutics such as precision medicine and immunotherapy – many of which are not widely available – patients have access to these cutting-edge therapies at Rutgers Cancer Institute of New Jersey in New Brunswick, Rutgers Cancer Institute of New Jersey at University Hospital in Newark, as well as through RWJBarnabas Health facilities. To make a tax-deductible gift to support the Cancer Institute of New Jersey, call 848-932-8013 or visit